Altered channel gating mechanism for CFTR inhibition by a high-affinity thiazolidinone blocker

被引:97
作者
Taddei, A
Folli, C
Zegarra-Moran, O
Fanen, P
Verkman, AS
Galietta, LJV [1 ]
机构
[1] Ist Giannina Gaslini, Genet Mol Lab, I-16148 Genoa, Italy
[2] Hop Henri Mondor, INSERM, U 468, F-94010 Creteil, France
[3] Univ Calif San Francisco, Dept Physiol & Med, San Francisco, CA 94143 USA
关键词
cystic fibrosis transmembrane conductance regulator; chloride channel; channel blocker; cystic fibrosis; chloride secretion;
D O I
10.1016/S0014-5793(04)00011-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The thiazolidinone CFTR(inh)-172 was identified recently as a potent and selective blocker of the cystic fibrosis transmembrane conductance regulator (CFTR) Cl(-) channel. Here, we characterized the CFTR(inh)-172 inhibition mechanism by patch-clamp and short-circuit analysis using cells stably expressing wild-type and mutant CFTRs. CFTR(inh)-172 did not alter CFTR unitary conductance (8 pS), but reduced open probability by > 90% with K(i) approximate to 0.6 muM. This effect was due to increased mean channel closed time without changing mean channel open time. Short-circuit current experiments indicated similar CFTR(inh)-172 inhibitory potency (K(i) approximate to 0.5 muM) for inhibition of Cl(-) current in wild-type, G551D, and G1349D CFTR,however, K(i) was significantly reduced to 0.2 muM for DeltaF508 CFTR. Our studies provide evidence for CFTR inhibition by CFTR(inh)-172 by a mechanism involving altered CFTR gating. (C) 2004 Published by Elsevier B.V. on behalf of the federation of European Biochemical Societies.
引用
收藏
页码:52 / 56
页数:5
相关论文
共 24 条
[1]   Pharmacological characterization of volume-sensitive, taurine permeable anion channels in rat supraoptic glial cells [J].
Brès, V ;
Hurbin, A ;
Duvoid, A ;
Orcel, H ;
Moos, FC ;
Rabié, A ;
Hussy, N .
BRITISH JOURNAL OF PHARMACOLOGY, 2000, 130 (08) :1976-1982
[2]  
Carew MA, 2000, J BIOL CHEM, V275, P26906
[3]   ALTERED CHLORIDE-ION CHANNEL KINETICS ASSOCIATED WITH THE DELTA-F508 CYSTIC-FIBROSIS MUTATION [J].
DALEMANS, W ;
BARBRY, P ;
CHAMPIGNY, G ;
JALLAT, S ;
DOTT, K ;
DREYER, D ;
CRYSTAL, RG ;
PAVIRANI, A ;
LECOCQ, JP ;
LAZDUNSKI, M .
NATURE, 1991, 354 (6354) :526-528
[4]   PROCESSING OF MUTANT CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR IS TEMPERATURE-SENSITIVE [J].
DENNING, GM ;
ANDERSON, MP ;
AMARA, JF ;
MARSHALL, J ;
SMITH, AE ;
WELSH, MJ .
NATURE, 1992, 358 (6389) :761-764
[5]   INDUCTION OF A GLIBENCLAMIDE-SENSITIVE K-CURRENT BY MODIFICATION OF A DELAYED RECTIFIER CHANNEL IN RAT PORTAL-VEIN AND INSULINOMA CELLS [J].
EDWARDS, G ;
WESTON, AH .
BRITISH JOURNAL OF PHARMACOLOGY, 1993, 110 (04) :1280-1281
[6]   IMPROVED PATCH-CLAMP TECHNIQUES FOR HIGH-RESOLUTION CURRENT RECORDING FROM CELLS AND CELL-FREE MEMBRANE PATCHES [J].
HAMILL, OP ;
MARTY, A ;
NEHER, E ;
SAKMANN, B ;
SIGWORTH, FJ .
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 1981, 391 (02) :85-100
[7]   Delta F508-CFTR channels: Kinetics, activation by forskolin, and potentiation by xanthines [J].
Haws, CM ;
Nepomuceno, IB ;
Krouse, ME ;
Wakelee, H ;
Law, T ;
Xia, Y ;
Nguyen, H ;
Wine, JJ .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 1996, 270 (05) :C1544-C1555
[8]   ATP hydrolysis by a CFTR domain: Pharmacology and effects of G551D mutation [J].
Howell, LD ;
Borchardt, R ;
Cohn, JA .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 271 (02) :518-525
[9]   Two mechanisms of genistein inhibition of cystic fibrosis transmembrane conductance regulator Cl- channels expressed in murine cell line [J].
Lansdell, KA ;
Cai, Z ;
Kidd, JF ;
Shepard, DN .
JOURNAL OF PHYSIOLOGY-LONDON, 2000, 524 (02) :317-330
[10]   CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR MUTATIONS THAT DISRUPT NUCLEOTIDE-BINDING [J].
LOGAN, J ;
HIESTAND, D ;
DARAM, P ;
HUANG, Z ;
MUCCIO, DD ;
HARTMAN, J ;
HALEY, B ;
COOK, WJ ;
SORSCHER, EJ .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (01) :228-236